Entrada Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	405	504	425	534
Market Cap Growth	-	18.58%	-20.54%	-
Enterprise Value	113	216	258	243
PE Ratio	-75.32	-75.32	-4.49	-10.44
PS Ratio	3.11	3.90	-	-
PB Ratio	1.65	2.08	2.00	1.79
P/FCF Ratio	2.99	3.75	-4.39	-9.64
P/OCF Ratio	2.87	3.60	-4.53	-10.51
EV/Sales Ratio	0.88	1.67	-	-
EV/EBITDA Ratio	7.60	14.49	-2.78	-4.86
EV/EBIT Ratio	9.39	17.90	-2.73	-4.75
EV/FCF Ratio	0.84	1.61	-2.67	-4.39
Debt / Equity Ratio	0.28	0.28	0.12	-
Debt / EBITDA Ratio	4.58	4.58	-0.28	-
Debt / FCF Ratio	0.51	0.51	-0.27	-
Quick Ratio	2.28	2.28	8.77	43.32
Current Ratio	2.33	2.33	9.55	44.46
Asset Turnover	0.27	0.27	0	0
Return on Equity (ROE)	-2.90%	-2.90%	-38.70%	-39.80%
Return on Assets (ROA)	-1.40%	-1.40%	-33.20%	-29.30%
Return on Capital (ROIC)	0.56%	0.56%	-40.78%	-17.12%
Earnings Yield	-1.67%	-1.33%	-22.28%	-9.57%
FCF Yield	33.48%	26.65%	-22.77%	-10.38%
Buyback Yield / Dilution	-5.61%	-5.61%	-399.27%	-467.09%
Total Shareholder Return	-5.61%	-5.61%	-399.27%	-467.09%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).